Ireland· IE-PA-PA1104/004/001
Flector Tissugel 140 mg medicated plaster
A diclofenac product containing diclofenac epolamine, registered in Ireland by IBSA Farmaceutici Italia S.r.l. The same ATC class is registered in 14 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Diclofenac is registered in 14 of 19 countries.
Countries holding a registration under ATC M02AA15 (diclofenac), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 8 of them publish a price we can compare per daily dose
Diclofenac · ATC M02AA15
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of diclofenac costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Diclofenac · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.43
The record
At a glance
HPRA (Ireland)- Active substance
- Diclofenac epolamine
- Manufacturer
- IBSA Farmaceutici Italia S.r.l
- Country
- Ireland (IE)
- ATC code
- M02AA15
- ATC class
- Diclofenac
- Defined daily dose
- 0.1 g, T
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1104/004/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
131 interactions on record for diclofenac.
Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Diclofenac · interactions on record
131 records
- 9 severe
- 122 moderate
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- PexidartinibL01EX15severe
- LeflunomidL04AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Diclofenac in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaFLALGOIBSA Slovakia s.r.o., Bratislava
- United Statesdiclofenac epolamineASCLEMED USA INC.
- BelgiumDiclofenac IBSA Farmaceutici 140 mgIBSA Farmaceutici Italia
- GermanyFlectorIbsa Farmaceutici Italia
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Austria · Flector Ep
- Belgium · Diclofenac Patch Ab, Flalgo
- Cyprus · Flector Tissugel
- Czechia · Flalgo, Flector
- Germany · Flector
- Denmark · Flector
- Spain · Flectormed
- France · Diclofenac Urgo, Flector
- United Kingdom (Northern Ireland) · Dicloalgan, Flector Tissugel
- Greece · Dicloplast, Miniflampatch
- Hungary · Diclofenac Epolamine Cooper, Flector
- Italy · Calminemed, Dicloreum
- Luxembourg · Flector Tissugel
- Poland · Diklofenak Viatris, Dolofest
- Portugal · Diclofenac Farmoz, Flector Tissugel
- Sweden · Flector
- Slovakia · Flectopar, Flector
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d35fd0ea-fe19-432b-b641-16d881821cc4 GET /v1/drugs/d35fd0ea-fe19-432b-b641-16d881821cc4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Medicated plaster",
"routes": [
"Cutaneous use"
],
"source": "hpra",
"atc_all": [
"M02AA",
"M02AA15"
],
"strength": null,
"pa_number": "PA1104/004/001",
"substances": [
"Diclofenac epolamine"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "04/11/2003",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about diclofenac.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.